Us Bancorp \De\ Bluebird Bio, Inc. Transaction History

Us Bancorp \De\

  • $75.6 Billion
  • Q4 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$0.85 - $1.26 $561 - $832
661 Added 49.33%
2,001 $1,000
Q1 2024

May 07, 2024
SELL
$0.91 - $1.75 $1,746 - $3,358
-1,919 Reduced 58.88%
1,340 $1,000
Q4 2023

Feb 09, 2024
BUY
$1.32 - $4.83 $2,378 - $8,703
1,802 Added 123.68%
3,259 $4,000
Q3 2023

Nov 03, 2023
SELL
$3.02 - $4.05 $18,283 - $24,518
-6,054 Reduced 80.6%
1,457 $4,000
Q2 2023

Aug 09, 2023
BUY
$2.79 - $5.03 $18,829 - $33,947
6,749 Added 885.7%
7,511 $24,000
Q1 2023

May 09, 2023
SELL
$3.14 - $8.22 $7,799 - $20,418
-2,484 Reduced 76.52%
762 $2,000
Q4 2022

Feb 13, 2023
SELL
$5.77 - $8.49 $26,957 - $39,665
-4,672 Reduced 59.0%
3,246 $22,000
Q3 2022

Oct 27, 2022
BUY
$3.75 - $7.39 $20,827 - $41,044
5,554 Added 234.94%
7,918 $50,000
Q2 2022

Aug 01, 2022
SELL
$2.94 - $5.23 $17,998 - $32,018
-6,122 Reduced 72.14%
2,364 $10,000
Q1 2022

May 11, 2022
BUY
$4.07 - $10.6 $15,657 - $40,778
3,847 Added 82.93%
8,486 $41,000
Q4 2021

Feb 11, 2022
BUY
$8.96 - $16.31 $33,465 - $60,917
3,735 Added 413.16%
4,639 $47,000
Q3 2021

Nov 10, 2021
SELL
$11.24 - $21.0 $69,710 - $130,242
-6,202 Reduced 87.28%
904 $17,000
Q2 2021

Aug 05, 2021
BUY
$18.04 - $22.09 $14,486 - $17,738
803 Added 12.74%
7,106 $227,000
Q1 2021

Apr 28, 2021
BUY
$16.59 - $33.89 $83,364 - $170,297
5,025 Added 393.19%
6,303 $190,000
Q4 2020

Feb 04, 2021
SELL
$27.5 - $37.92 $17,517 - $24,155
-637 Reduced 33.26%
1,278 $55,000
Q3 2020

Nov 10, 2020
SELL
$34.44 - $43.75 $90,818 - $115,368
-2,637 Reduced 57.93%
1,915 $103,000
Q2 2020

Aug 07, 2020
SELL
$27.12 - $45.97 $22,374 - $37,925
-825 Reduced 15.34%
4,552 $277,000
Q1 2020

May 13, 2020
BUY
$26.16 - $63.5 $65,792 - $159,702
2,515 Added 87.88%
5,377 $247,000
Q4 2019

Feb 04, 2020
SELL
$46.96 - $61.67 $57,244 - $75,175
-1,219 Reduced 29.87%
2,862 $252,000
Q3 2019

Nov 08, 2019
SELL
$59.47 - $93.1 $2,378 - $3,724
-40 Reduced 0.97%
4,081 $375,000
Q2 2019

Aug 13, 2019
SELL
$75.84 - $105.21 $151 - $210
-2 Reduced 0.05%
4,121 $524,000
Q1 2019

May 08, 2019
BUY
$64.44 - $104.11 $73,203 - $118,268
1,136 Added 38.03%
4,123 $649,000
Q4 2018

Feb 13, 2019
SELL
$59.1 - $93.26 $79,430 - $125,341
-1,344 Reduced 31.03%
2,987 $297,000
Q3 2018

Nov 01, 2018
BUY
$88.86 - $117.49 $26,035 - $34,424
293 Added 7.26%
4,331 $632,000
Q2 2018

Aug 08, 2018
BUY
$99.64 - $127.59 $99 - $127
1 Added 0.02%
4,038 $634,000
Q1 2018

May 08, 2018
BUY
$105.8 - $150.94 $423,834 - $604,665
4,006 Added 12922.58%
4,037 $689,000
Q4 2017

Feb 02, 2018
SELL
$81.25 - $130.7 $13,731 - $22,088
-169 Reduced 84.5%
31 $6,000
Q3 2017

Nov 13, 2017
BUY
$57.74 - $91.42 $11,548 - $18,284
200
200 $27,000

Others Institutions Holding BLUE

# of Institutions
112
Shares Held
61.5M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $485M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email